← Library

KPV

Peptide

Targeted Anti-Inflammatory & Gut Health Support

A small three-amino-acid peptide that represents the active anti-inflammatory portion of your body's own alpha-MSH hormone — designed to calm inflammation and promote restorative health.

Suggested use: Many protocols begin at the low end of the range for the first week to assess tolerance, then increase under physician supervision based on response. Cycling (for example, several weeks on followed by a short break) is common given the limited long-term human data.

May help with

chronic gut inflammationinflammatory bowel conditionsleaky guteczemapsoriasisautoimmune inflammationhistamine sensitivitylung inflammationchronic inflammation

Key ingredients

  • KPV (Lys-Pro-Val tripeptide)
  • alpha-MSH fragment

Product handout

KPV

Targeted Anti-Inflammatory & Gut Health Support

WHAT IT IS:

A small three-amino-acid peptide that represents the active anti-inflammatory portion of your body's own alpha-MSH hormone — designed to calm inflammation and promote restorative health.

WHY YOU NEED IT:

  • Targeted Calming of the Inflammatory Response, including lung related disorders
  • Important for patients with chronic gut inflammation, including inflammatory bowel conditions and "leaky gut" concerns
  • Supports patients with inflammatory skin issues such as eczema, psoriasis, and slow-healing irritation
  • Good for patients seeking an alternative or complement to long-term steroids or NSAIDs
  • Great for patients managing autoimmune-related inflammation or histamine sensitivity
  • Supports patients pursuing comprehensive gut repair, often alongside healing peptides such as BPC-157
  • Important for patients who prefer a peptide that can be taken orally for gut-targeted support

HOW IT HELPS:

Inflammation sits at the root of a remarkable range of chronic complaints — from tummy troubles to stubborn skin conditions. KPV is designed to work with one of your body's own built-in "off switches" for inflammation rather than broadly suppressing the immune system.

A Naturally Derived Anti-Inflammatory Signal

KPV is a tiny, molecular piece of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH), a peptide your body already makes. Research suggests it works largely by quieting NF-κB, a master switch that drives many inflammatory cascades all over your body, but especially in your skin, lungs, and intestines. Because it is such a small molecule, it can act inside cells where larger anti-inflammatory agents cannot easily reach. As it has been said and is true: the Cat can do what the Tiger cannot.

Particular Promise in the Gut

KPV has its most extensive research base in the digestive tract. In animal models of colitis, oral KPV reduced inflammatory markers and helped preserve the integrity of the intestinal lining. Notably, the same transporter (PepT1) that carries KPV inside of gut cells happens to be more active in inflamed tissue — a self-targeting feature that has made KPV especially interesting for gut-focused protocols.

Skin and Whole-Body Support

Beyond the gut, KPV has been explored topically for inflammatory skin conditions and systemically for broader inflammatory support. Many patients are drawn to it as a gentler-feeling option for managing the day-to-day burden of chronic inflammation.

What to Expect

KPV is generally well tolerated, reflecting its origin as a natural peptide fragment. Gut-related improvements are sometimes noticed within the first couple of weeks, while broader anti-inflammatory effects may build more gradually. Reported side effects are mild and uncommon, such as transient skin irritation with topical use or minor digestive upset.

Who Should Not Use KPV

KPV is not appropriate for women who are pregnant or breastfeeding, patients with a known hypersensitivity to the peptide, or those with active malignancy or other serious medical conditions without physician oversight. Because human data remain limited, KPV should be used only under the guidance of a qualified clinician.

DOSAGE:

Titration: Many protocols begin at the low end of the range for the first week to assess tolerance, then increase under physician supervision based on response. Cycling (for example, several weeks on followed by a short break) is common given the limited long-term human data.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.*